Are there predictors that can determine neoadjuvant treatment responses in rectal cancer?

Rakici S., Bedir R., Hatipoglu C.

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.30, sa.3, ss.220-227, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5152/tjg.2018.18179
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.220-227
  • Anahtar Kelimeler: Rectal neoplasms, neoadjuvant treatment, DNA mismatch repair, microsatellite instability, P53 genes, neutrophil-lymphocyte ratio, PREOPERATIVE CHEMORADIOTHERAPY, COLORECTAL-CANCER, PATHOLOGICAL RESPONSE, MICROSATELLITE-INSTABILITY, LYMPHOCYTE RATIO, P53, EXPRESSION, RADIATION, SURGERY
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Background/Aims: This study aimed to determine a predictive bioindicator that would detect the treatment response of patients diagnosed with rectal cancer and treated with neoadjuvant chemoradiotherapy (nCRT).